Author Information
Miłosz Parczewski is affiliated with the Department of Infectious, Tropical Diseases and Immune Deficiency at the Pomeranian Medical University in Szczecin, Poland. His research expertise spans various aspects of infectious diseases, with a particular focus on HIV/AIDS, COVID-19, and hepatitis C. His work is pivotal in understanding immune restoration in people living with HIV/AIDS and exploring therapeutic interventions for COVID-19.Research Contributions
Miłosz Parczewski has made significant contributions to the field of infectious diseases through his extensive research on HIV/AIDS, COVID-19, and hepatitis C. In 2022, he authored several impactful papers, including studies on immune restoration in HIV/AIDS patients, the effectiveness of Tocilizumab in severe COVID-19 cases, and the immune signature of COVID-19. His research also includes insights into hepatitis C resistance patterns after the introduction of direct-acting antivirals. His work plays an essential role in shaping treatment strategies and understanding disease mechanisms, particularly in the Polish population.Aliases
Miłosz Parczewski is known by several aliases, including M Parczewski, M. Parczewski, and Milosz Parczewski. These variations are used in different publications and databases.Publication and Citation Metrics
| Total Citation Count |
1149 |
| H-index |
17 |
| Total Number of Papers |
167 |
